Validation of an Analytical Model for Therapeutic and Stray Dose Calculations of 6 MV Photon Beams

摘要

Cancer is one of the most significant health care problems today. It is estimated that 1 in 2 men and women will be diagnosed with some form of cancer in their lifetime. Nearly two thirds of cancer patients will receive radiation therapy at some point in their care and the vast majority of these radiotherapy treatments will be performed with megavoltage photon therapy. Photon treatment techniques typically devote considerable attention to limiting the exposure of healthy tissues outside of the intended treatment volume. Nonetheless, small levels of unwanted stray radiation are incident upon the patient's whole body, which can increase the risk for numerous late effects, including second malignancies. When one considers that second cancers account for approximately 15% of all cancers and that it is projected that by the year 2020, there will be almost 20 million cancer survivors in the United States and four million in the UK, the need for improved accuracy in stray dose calculations appears likely to increase dramatically.